A research coordinator discovers a participant has experienced an unexpected serious adverse event. What is the FIRST priority action?
-
A
Complete and submit the MedWatch form to the FDA
-
B
Ensure the participant receives appropriate medical care immediately
-
C
Notify the sponsor's medical monitor before taking any other steps
-
D
Unblind the participant's treatment assignment to assess causality